QPCT is considered attractive therapeutic targets in many human disorders, such as neurodegenerative diseases, and a range of inflammatory conditions, as well as for cancer immunotherapy, because of their capacity to modulate cancer immune checkpoint proteins (20, 21). This evidence concerns the gene QPCT and neurodegenerative disease.